You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-BCR (BCR) Antibodies

Full name:
anti-Breakpoint Cluster Region Antibodies (BCR)
On are 177 Breakpoint Cluster Region (BCR) Antibodies from 20 different suppliers available. Additionally we are shipping BCR Kits (15) and BCR Proteins (7) and many more products for this protein. A total of 206 BCR products are currently listed.
5133400C09Rik, AI561783, AI853148, ALL, BCR, BCR1, CML, D22S11, D22S662, mKIAA3017, PHL, si:dkey-83d9.7, zK83D9.7
list all antibodies Gene Name GeneID UniProt
BCR 613 P11274
BCR 110279 Q6PAJ1
BCR 309696  

Show all species

Show all synonyms

Most Popular Reactivities for anti-BCR (BCR) Antibodies

Select your species and application

anti-Human BCR Antibodies:

anti-Mouse (Murine) BCR Antibodies:

anti-Rat (Rattus) BCR Antibodies:

All available anti-BCR Antibodies

Go to our pre-filtered search.

Top referenced anti-BCR Antibodies

  1. Human Polyclonal BCR Primary Antibody for IF, WB - ABIN197420 : Sattler, Verma, Byrne, Shrikhande, Winkler, Algate, Rohrschneider, Griffin: BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis. in Molecular and cellular biology 1999 (PubMed)
    Show all 4 references for ABIN197420

  2. Human Polyclonal BCR Primary Antibody for IHC (p), WB - ABIN196938 : Million, Harakawa, Roumiantsev, Varticovski, Van Etten: A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. in Molecular and cellular biology 2004 (PubMed)
    Show all 4 references for ABIN196938

  3. Human Polyclonal BCR Primary Antibody for IF, WB - ABIN362836 : Li, Couvillon, Brasher, Van Etten: Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. in The EMBO journal 2001 (PubMed)
    Show all 3 references for ABIN362836

More Antibodies against BCR Interaction Partners

Human Breakpoint Cluster Region (BCR) interaction partners

  1. though our data support the previous findings that co-expression of BCR-ABL transcripts is due to the occurrence of exonic and intronic polymorphisms in the BCR gene, it also shows that the intronic polymorphism can arise without the linked exonic polymorphism. The occurrence of ABL kinase domain mutation is less frequent in Indian population.

  2. In silico three-dimensional modeling of apoptin, molecular docking experiments between apoptin model and the known structure of Bcr-Abl (show ABL1 Antibodies), and the 3D structures of SH2 domains of CrkL (show CRKL Antibodies) and Bcr-Abl (show ABL1 Antibodies), were performed.

  3. The present study screened for the presence of bcr-abl (show ABL1 Antibodies) transcripts in the blood of a group of healthy individuals.

  4. Data indicate that the biosensor showed excellent analytical performance for the detection of the BCR/ABL oncogene in clinical samples of patients with leukemia.

  5. Studies indicate that the prognosis of BCR-ABL (show ABL1 Antibodies)-positive acute myeloid leukemia (show BCL11A Antibodies) (BCR-ABL (show ABL1 Antibodies)+ AML (show RUNX1 Antibodies)) seems to depend on the cytogenetic and/or molecular background rather than on BCR-ABL (show ABL1 Antibodies) itself.

  6. demonstrated that depletion of endogenous MAPK15 (show MAPK15 Antibodies) expression inhibited BCR-ABL1 (show ABL1 Antibodies)-dependent cell proliferation

  7. Identify a novel BCR-ABL (show ABL1 Antibodies)/IkappaBalpha (show NFKBIA Antibodies)/p53 (show TP53 Antibodies) network, whereby BCR-ABL (show ABL1 Antibodies) functionally inactivates a key tumor suppressor in chronic myeloid leukemia (show BCL11A Antibodies).

  8. Blockade of the interaction between Bcr-Abl (show ABL1 Antibodies) and PTB1B by small molecule SBF-1 (show SBF1 Antibodies) to overcomes imatinib-resistance of K562 cells.

  9. BCR-ABL1 transcript types found in Syria were similar to that of Indian Far-Eastern, African or European populations. The M-BCR rearrangement types were not dependent on white blood count, platelet count, hemoglobin level or gender of the patients.

  10. Data suggest elevated interleukin-1beta secretion from tyrosine kinase (show TXK Antibodies) inhibitor- (TKI-)resistant chronic myeloid leukemia (show BCL11A Antibodies) (CML) cells contributes to TKI/imatinib resistance via promotion of cell viability/migration; cells used lack BCR-ABL (show ABL1 Antibodies) mutation.

Mouse (Murine) Breakpoint Cluster Region (BCR) interaction partners

  1. BCR signaling elicits maximal cell death through upregulation of multiple BH3-only (show BBC3 Antibodies) proteins; namely Bim (show BCL2L11 Antibodies), Bik (show BIK Antibodies), and Noxa (show PMAIP1 Antibodies).

  2. The resistance in BCR-ABL1 (show ABL1 Antibodies) cells resulted either from the Y253H mutation in the BCR-ABL1 (show ABL1 Antibodies) gene or incubation in increasing concentrations of imatinib.

  3. PDZK1 (show PDZK1 Antibodies) has novel SR-BI (show SCARB1 Antibodies)-independent function in VSM that affords protection from neointima formation, and this involves PDZK1 (show PDZK1 Antibodies) suppression of VSM cell proliferation via an inhibitory interaction with Bcr

  4. Hap1 (show HAP1 Antibodies) interacts with Bcr on microtubules to regulate neuronal differentiation.

  5. Grb10 (show GRB10 Antibodies) is involved in BCR-ABL (show ABL1 Antibodies)-positive leukemia in mice.

  6. Bcr is an integral member of the Par (show AFG3L2 Antibodies)-Tiam1 (show TIAM1 Antibodies) complex that controls polarized cell migration by locally restricting both Rac1 and PKCzeta (show PRKCZ Antibodies) function.

  7. Loss of Bcr expression causes defects in spine development.

  8. Suggest that HS-438 may be a novel drug candidate with the therapeutic potential to target BCR-ABL (show ABL1 Antibodies) and overcome imatinib resistance in patients with chronic myeloid leukemia (show BCL11A Antibodies).

  9. IRF8 (show IRF8 Antibodies)-rescued BCR-ABL (show ABL1 Antibodies)-expressing dendritic cells were capable of inducing CTLs more efficiently than control dendritic cells.

  10. study provided evidence for a novel, BCR-ABL (show ABL1 Antibodies)-mediated antiapoptotic mechanism, which results from the increased acetylation of p53 (show TP53 Antibodies) at the K317/K320 residue, thus preventing the nuclear export of p53 (show TP53 Antibodies) in response to DNA damage.

BCR Antigen Profile

Antigen Summary

A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with BCR

  • breakpoint cluster region (bcr) antibody
  • breakpoint cluster region (BCR) antibody
  • breakpoint cluster region (Bcr) antibody
  • 5133400C09Rik antibody
  • AI561783 antibody
  • AI853148 antibody
  • ALL antibody
  • BCR antibody
  • BCR1 antibody
  • CML antibody
  • D22S11 antibody
  • D22S662 antibody
  • mKIAA3017 antibody
  • PHL antibody
  • si:dkey-83d9.7 antibody
  • zK83D9.7 antibody

Protein level used designations for BCR

breakpoint cluster region , breakpoint cluster region protein-like , BCR/FGFR1 chimera protein , FGFR1/BCR chimera protein , breakpoint cluster region protein , renal carcinoma antigen NY-REN-26 , breakpoint cluster region homolog

568320 Danio rerio
100393591 Callithrix jacchus
100431481 Pongo abelii
458694 Pan troglodytes
100554393 Anolis carolinensis
613 Homo sapiens
110279 Mus musculus
309696 Rattus norvegicus
100157974 Sus scrofa
100718992 Cavia porcellus
416952 Gallus gallus
607482 Canis lupus familiaris
789892 Bos taurus
Selected quality suppliers for anti-BCR (BCR) Antibodies
Did you look for something else?